Psychopharmacology

, Volume 106, Issue 3, pp 401–407 | Cite as

Effects of chronically administered fluoxetine and fenfluramine on food intake, body weight and the behavioural satiety sequence

  • Joan McGuirk
  • Richard Muscat
  • Paul Willner
Original Investigations
Received:
Revised:

Abstract

Rats were administered fenfluramine (FF: 3 mg/kg) or fluoxetine (FX: 6 mg/kg) daily for 3 weeks. On acute administration, FF suppressed consumption of 35% sucrose (in a 40 min test) and overnight chow intake. Repeated administration saw the rapid development of extensive tolerance to these effects. FF had no effects on body weight, and no withdrawal effects were apparent. FX reduced chow intake and body weight throughout the treatment period, but there was evidence of some tolerance to the suppression of chow intake and sucrose drinking. Following FX withdrawal, normal body weight was restored in 4 days; food intake was normal during this period. A delayed rebound hyperphagia commenced on day 5 of withdrawal, and persisted for at least 6 days. The behavioural satiety sequence (drinking -activity - grooming - resting) was disrupted by acute FF; on chronic treatment, FF advanced the onset of postprandial resting, but also increased drinking time. FX advanced the behavioural satiety sequence on acute administration, but not after chronic treatment. We consider the implications of these results for the use of resting behaviour as an indicator of postprandial satiety.

Key words

Feeding Body weight Fluoxetine Fenfluramine Behavioural satiety sequence Chronic drug treatment Rat 
This is a preview of subscription content, log in to check access.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Angel I, Taranger M-A, Claustre Y, Scatton B, Langer SZ (1988) Anorectic activities of serotonin uptake inhibitors: Correlation with their potencies at inhibiting serotonin uptake in vivo and3H-mazindol binding in vitro. Life Sci 43:651–658Google Scholar
  2. Antin J, Gibbs J, Holt J, Young RC, Smith GP (1975) Cholecystokinin elicits the complete behavioural sequence of satiety in rats. Physiol Psychol 89:784–790Google Scholar
  3. Blundell JE (1986) Serotonin manipulations and the structure of feeding behaviour. Appetite 7[suppl]:39–56Google Scholar
  4. Burton MJ, Cooper SJ, Popplewell DA (1981) The effect of fenfluramine on the microstructure of feeding and drinking in the rat. Br J Pharmacol 72:621–633Google Scholar
  5. Caccia S, Cappi M, Fracasso C, Garattini S (1990) Influence of dose and route of administration on the kinetics of fluoxetine and its metabolite norfluoxetine in the rat. Psychopharmacology 100:509–514Google Scholar
  6. Clifton PG, Barnfield AMC, Philcox L (1989) A behavioural profile of fluoxetine-induced anorexia. Psychopharmacology 97:89–95Google Scholar
  7. Cooper SJ, Francis RL (1979) Feeding parameters with two food textures after chlordiazepoxide administration, alone or in combination withd-amphetamine or fenfluramine. Psychopharmacology 62:253–259Google Scholar
  8. Foltin RW, Fischman MW (1988) Food intake in baboons: effects ofd-amphetamine and fenfluramine. Pharmacol Biochem Behav 31:585–592Google Scholar
  9. Fuller RW, Wong DT (1977) Inhibition of serotonin uptake. Fed Proc 36:2154–2158Google Scholar
  10. Fuller RW, Snoddy HD, Robertson DW (1988) Mechanisms of effects ofd-fenfluramine on brain serotonin metabolism in rats: uptake inhibition versus release. Pharmacol Biochem Behav 30:715–721Google Scholar
  11. Garattini S, Mennini T, Bendotti C, Invernizzi R, Samanin R (1986) Neurochemical mechanism of action of drugs which modify feeding via the serotonergic system. Appetite 7 [suppl]:15–38Google Scholar
  12. Guy-Grand B, Apfelbaum M, Crepaldi G, Gries A, Lefebre P, Turner P (1989) International trial of long-term dexfenfluramine in obesity. Lancet ii:1142–1145Google Scholar
  13. Hudson KD (1977) The anorectic and hypotensive effect of fenfluramine in obesity. J R Coll Gen Pract 27:497Google Scholar
  14. Hutson PH, Donohoe TP, Curzon G (1988) Infusion of the 5-hydroxytryptamine agonists RU 24969 and TFMPP into the paraventricular nucleus of the hypothalamus causes hypophagia. Psychopharmacology 95:550–552Google Scholar
  15. Kennett GA, Dourish CT, Curzon G (1987) 5-HT1B agonists induce anorexia at a post-synaptic site. Eur J Pharmacol 141:429–435Google Scholar
  16. Kinney-Parker J, Smith D, Ingle SF (1989) Fluoxetine and weight: something lost and something gained? Clin Pharm 8:727–733Google Scholar
  17. Kushner LR, Mook DG (1984) Behavioural correlates of oral and post-ingestive satiety in the rat. Physiol Behav 33:713–718Google Scholar
  18. Leander JD (1987) Fluoxetine suppresses palatability-induced ingestion. Psychopharmacology 91:285–287Google Scholar
  19. Levine LR, Rosenblatt S, Bosomworth J (1987) Use of a serotonin reuptake inhibitor, fluoxetine, in the treatment of obesity. Int J Obes 11 [suppl 3]:185–190Google Scholar
  20. Lucki I, Kreider MS, Simansky KJ (1988) Reduction of feeding behaviour by the serotonin uptake inhibitor sertraline. Psychopharmacology 96:289–295Google Scholar
  21. McGuirk J, Silverstone T (1990) The effect of the 5-HT reuptake inhibitor fluoxetine on food intake and body weight in healthy male subjects. Int J Obes 14:361–372Google Scholar
  22. McGuirk J, Goodall E, Silverstone T, Willner P (1991a) Differential effects ofd-fenfluramine,l-fenfluramine andd-amphetamine on the microstructure of human eating behaviour. Behav Pharmacol 2:113–119Google Scholar
  23. McGuirk J, Muscat R, Willner P (1991b) Effects of the 5-HT uptake inhibitors, femoxetine and paroxetine, and a 5-HT1A/B agonist, eltoprazine, on the behavioural safety sequence. Pharmacol Biochem Behav (in press)Google Scholar
  24. Mennini T, De Blasi A, Borroni E, Bendotti C, Borsini F, Samanin R, Garattini S (1981) Biochemical and functional studies on tolerance to anorectic activity ofd-fenfluramine in comparison withd-amphetamine. In: Garattini S, Samanin R (eds) Anorectic agents: mechanisms of action and tolerance. Raven Press, New York, pp 87–100Google Scholar
  25. Monro JF, Ford MJ (1982) Drug treatment of obesity. In: Silverstone T (ed) Drugs and appetite. Academic Press, London, pp 125–157Google Scholar
  26. Montgomery AMJ, Willner P (1988) Fenfluramine disrupts the behavioural satiety sequence in rats. Psychopharmacology 94:397–401Google Scholar
  27. Morley JE, Flood JF (1987) An investigation of tolerance to the actions of leptogenic and anorexigenic drugs in mice. Life Sci 41:2157–2165Google Scholar
  28. Neill JC, Cooper SJ (1989) Evidence thatd-fenfluramine anorexia is mediated by 5-HT1 receptors. Psychopharmacology 97:213–218Google Scholar
  29. Pinder RM, Brogden RN, Gawyer RR, Speight TM, Avery GS (1975) Fenfluramine: a review of its pharmacological properties and its therapeutic efficacy in obesity. Drugs 10:241–323Google Scholar
  30. Rowland NE (1986) Effect of continuous infusions of dexfenfluramine on food intake, body weight and brain amines in rats. Life Sci 39:2581–2586Google Scholar
  31. Rowland NE, Carlton J (1986) Tolerance to fenfluramine anorexia: fact or fiction? Appetite 7 [suppl]:71–83Google Scholar
  32. Rowland NE, Antelman SM, Kocan D (1982) Differences among “serotonergic” anorectics in a cross-tolerance paradigm: do they all act on serotonin systems? Eur J Pharmacol 81:57–66Google Scholar
  33. Samanin R, Mennini T, Bendotti C, Barone D, Caccia S, Garattini S (1989) Evidence that central 5-HT2 receptors do not play an important role in the anorectic activity ofd-fenfluramine in the rat. Neuropharmacology 28:465–469Google Scholar
  34. Smith GP, Gibbs J (1975) Postprandial satiety. In: Sprague JM, Epstein AN (eds) Progress in psychobiology and physiological psychology, vol 8. Academic Press, New York, pp 180–242Google Scholar
  35. Willner P (1989) Sensitization to the effects of antidepressant drugs. In: Goudie AJ, Emmett-Oglesby MW (eds) Psychoactive drugs: tolerance and sensitization. Humana, Clifton, pp 407–459Google Scholar
  36. Willner P, McGuirk J, Phillips G, Muscat R (1990) Behavioural analysis of the anorectic effects of fluoxetine and fenfluramine. Psychopharmacology 102:273–277Google Scholar
  37. Wong DT, Reid LR, Bymaster FP, Threlkeld PG (1985) Chronic effects of fluoxetine, a selective inhibitor of serotonin uptake, on neurotransmitter receptors. J Neural Transm 64:251–269Google Scholar

Copyright information

© Springer-Verlag 1992

Authors and Affiliations

  • Joan McGuirk
    • 1
  • Richard Muscat
    • 1
  • Paul Willner
    • 1
  1. 1.Psychology DepartmentCity of London PolytechnicLondonUK

Personalised recommendations